Anatara Lifesciences Ltd (anr) Logo

Anatara Lifesciences Ltd (ANR)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

ANR ASX Chart

Snapshot

Anatara Lifesciences Ltd (ANR) is developing and commercializing, evidence-based products for gastrointestinal health where there is unmet need. It is a life sciences company developing products for animal and human health and is focused on building a pipeline of human gastrointestinal health products. Anatara is focused on building a pipeline of human gastrointestinal health products.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +67.84%
vs ASX 200 (1yr) +56.99%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,970 of 2,384
Sector Rank 191 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies TD1 / JHL / GLH
EPS -$0.013
DPS $0.00
Book Value Per Share $0.006

Broker Consensus

ANR is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Carlton South VIC 3053
Website www.anataralifesciences.com
Registry Computershare
Auditor Grant Thornton Audit Pty Ltd
Date Listed 16 Oct 2014

Upcoming Calendar (Forecasted)

Date Event
22/08/2024 Report (Prelim)
14/10/2024 Report (Prelim)
14/10/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • Anatara Lifesciences Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ANR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
11/12/23 David Brookes Issued 750,000 $0.022 $16,500 Rights issue
11/12/23 David Brookes Issued 750,000 $0.022 $16,500 Rights issue
11/12/23 John Michailidis Issued 250,000 $0.022 $5,500 Rights issue
08/12/23 David Brookes Issued 725,716 $0.022 $15,965 Rights issue
08/12/23 David Brookes Issued 140,000 $0.022 $3,080 Rights issue
08/12/23 John Michailidis Issued 200,000 $0.022 $4,400 Rights issue
19/12/22 Jane Ryan Issued 71,429 $0.038 $2,714 Issue of options
19/12/22 David Brookes Issued 857,143 $0.038 $32,571 Issue of options
16/12/22 David Brookes Issued 1,364,286 $0.038 $51,842 Issue of securities
16/12/22 David Brookes Issued 350,000 $0.038 $13,300 Issue of securities
16/12/22 Jane Ryan Issued 142,858 $0.035 $5,000 Issue of securities
12/12/22 David Brookes Cancelled 65,658 $0.035 $2,298 Cancellation of securities
28/11/22 David Brookes Issued 150,000 $0.035 $5,250 Rights issue
09/12/21 Jane Ryan Issued 450,000 $0.140 $63,000 Issue of options
09/12/21 Sue MacLeman Issued 450,000 $0.140 $63,000 Issue of options
09/12/21 David Brookes Issued 900,000 $0.140 $126,000 Issue of options
08/09/21 Sue MacLeman Buy +32,259 $0.159 $5,126 On-market trade
03/12/20 David Brookes Issued 65,658 $0.175 $11,490 Issue of options
03/12/20 Jane Ryan Issued 65,658 $0.175 $11,490 Issue of options
03/12/20 Sue MacLeman Issued 122,548 $0.175 $21,445 Issue of options
18/11/20 David Brookes Buy +200,000 $0.150 $30,000 Participation in share purchase plan
18/11/20 Jane Ryan Buy +133,333 $0.150 $19,999 Participation in share purchase plan
18/11/20 Sue MacLeman Buy +33,333 $0.150 $4,999 Participation in share purchase plan
22/11/19 Tracie Ramsdale Buy +106,810 $0.210 $22,430 Conversion of securities
01/11/19 Jane Ryan Buy +49,745 $0.191 $9,482 On-market trade
01/11/19 David Brookes Buy +50,000 $0.195 $9,750 On-market trade
05/03/19 Sue MacLeman Buy +12,477 $0.396 $4,947 On-market trade
26/02/19 David Brookes Buy +50,000 $0.408 $20,401 On-market trade
22/06/18 Iain Ross Buy +50,000 $0.612 $30,603 On-market trade
30/06/16 Melvyn Bridges Buy +12,284 $1.27 $15,563 On-market trade
28/06/16 Iain Ross Buy +33,828 $1.24 $41,927 On-market trade
13/05/16 Paul Grujic Buy +30,000 $1.19 $35,678 On-market trade
22/04/16 Melvyn Bridges Buy +30,000 $1.21 $36,424 On-market trade
29/07/15 Melvyn Bridges Buy +19,356 $0.780 $15,098 Participation in share purchase plan
29/07/15 David (Jay) Hetzel Buy +11,614 $0.780 $9,059 Participation in share purchase plan
29/07/15 Iain Ross Buy +11,614 $0.780 $9,059 Participation in share purchase plan
29/07/15 Paul Grujic Buy +11,614 $0.780 $9,059 Participation in share purchase plan
29/07/15 Tracie Ramsdale Buy +11,614 $0.780 $9,059 Participation in share purchase plan
20/04/15 Iain Ross Buy +29,000 $0.697 $20,210 On-market trade
23/12/14 Melvyn Bridges Buy +57,000 $0.307 $17,521 On-market trade
10/12/14 Melvyn Bridges Buy +9,000 $0.337 $3,032 On-market trade
25/11/14 Iain Ross Buy +28,500 $0.356 $10,133 On-market trade
17/10/14 Melvyn Bridges Buy +68,500 $0.410 $28,074 On-market trade
Show All

Director Interests

The current holdings of ANR directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
John Michailidis 11/12/2023 N/A 949,999 250,000 N/A
David Brookes 11/12/2023 1,240,000 3,290,002 1,832,143 N/A
Nicholas Haslam 07/12/2022 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Jun 30, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Rtl Group Investments Pty Ltd <The Rtl Investment A/C> 12,542,857 10.46%
Ubs Nominees Pty Ltd 8,494,808 7.08%
Scintilla Strategic Investments Limited 6,357,142 5.30%
Parma Corporation Pty Ltd 4,667,681 3.89%
Myeng Pty Ltd 3,580,211 2.99%
Mr Bertrand Lalanne 3,300,000 2.75%
Himstedt & Co Pty Ltd <The Himstedt Family A/C> 3,142,857 2.62%
Calama Holdings Pty Ltd <Mambat Super Fund A/C> 2,663,987 2.22%
Mr Michael Andrew Whiting + Mrs Tracey Anne Whiting <Whiting Family S/F A/C> 2,500,000 2.08%
Symington Pty Ltd 2,100,000 1.75%
Mr Samuel Francis Hunter 2,080,729 1.74%
Octifil Pty Ltd 2,000,000 1.67%
Mr Brendan Phyland 1,894,042 1.58%
Candour Asset Management Pty Ltd 1,548,056 1.29%
Gp Securities Pty Ltd 1,500,000 1.25%
Slade Technologies Pty Ltd <Embrey Family Superfund A/C> 1,500,000 1.25%
Longridge Partners Pty Ltd 1,400,000 1.17%
Toucan Trading Pty Ltd 1,371,429 1.14%
Dr David Lionel Brookes + Mrs Elisabeth Brookes <Dr Dl Brookes Persnl S/F A/C> 1,242,858 1.04%
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 1,096,345 0.91%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 43 133 132 291 145 744

Substantial Shareholders

No Substantial Shareholders for ANR in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.028 30 June
2022 $0.055 30 June
2021 $0.155 30 June
2020 $0.130 30 June
2019 $0.255 28 June
2018 $0.635 29 June
2017 $1.000 28 June
2016 $1.26 28 June
2015 $1.000 30 June
ANR Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.